Zheng M - Search Results

1

Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells.

Wang YQ, Shen AJ, Sun JY, Wang X, Liu HC, Zhang MM, Chen DQ, Xiong B, Shen JK, Geng MY, Zheng M, Ding J. Wang YQ, et al. Among authors: zheng m. Acta Pharmacol Sin. 2016 Dec;37(12):1587-1596. doi: 10.1038/aps.2016.85. Epub 2016 Sep 12. Acta Pharmacol Sin. 2016. PMID: 27616574 Free PMC article.

2

Author Correction: Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells.

Wang YQ, Shen AJ, Sun JY, Wang X, Liu HC, Zhang MM, Chen DQ, Xiong B, Shen JK, Geng MY, Zheng M, Ding J. Wang YQ, et al. Among authors: zheng m. Acta Pharmacol Sin. 2020 May;41(5):731-732. doi: 10.1038/s41401-019-0341-6. Acta Pharmacol Sin. 2020. PMID: 32081977 Free PMC article.

3

Cholera toxin inhibits human hepatocarcinoma cell proliferation in vitro via suppressing ATX/LPA axis.

Xia Q, Deng AM, Wu SS, Zheng M. Xia Q, et al. Among authors: zheng m. Acta Pharmacol Sin. 2011 Aug;32(8):1055-62. doi: 10.1038/aps.2011.31. Epub 2011 Jul 18. Acta Pharmacol Sin. 2011. PMID: 21765444 Free PMC article.

4

Involvement of REST corepressor 3 in prognosis of human hepatitis B.

Xue JH, Zheng M, Xu XW, Wu SS, Chen Z, Chen F. Xue JH, et al. Among authors: zheng m. Acta Pharmacol Sin. 2011 Aug;32(8):1019-24. doi: 10.1038/aps.2011.49. Epub 2011 Jul 18. Acta Pharmacol Sin. 2011. PMID: 21765449 Free PMC article.

5

Dual inhibiting OCT4 and AKT potently suppresses the propagation of human cancer cells.

Li W, Zhou Y, Zhang X, Yang Y, Dan S, Su T, She S, Dong W, Zhao Q, Jia J, Yao H, Zheng M, Kang B, Wang YJ. Li W, et al. Among authors: zheng m. Sci Rep. 2017 Apr 6;7:46246. doi: 10.1038/srep46246. Sci Rep. 2017. PMID: 28383051 Free PMC article.

6

EGCG attenuates pro-inflammatory cytokines and chemokines production in LPS-stimulated L02 hepatocyte.

Liu Q, Qian Y, Chen F, Chen X, Chen Z, Zheng M. Liu Q, et al. Among authors: zheng m. Acta Biochim Biophys Sin (Shanghai). 2014 Jan;46(1):31-9. doi: 10.1093/abbs/gmt128. Epub 2013 Nov 21. Acta Biochim Biophys Sin (Shanghai). 2014. PMID: 24269954 Free article.

7

Interferon-α sensitizes HBx-expressing hepatocarcinoma cells to chemotherapeutic drugs through inhibition of HBx-mediated NF-κB activation.

Liu Y, Lou G, Wu W, Shi Y, Zheng M, Chen Z. Liu Y, et al. Among authors: zheng m. Virol J. 2013 May 29;10:168. doi: 10.1186/1743-422X-10-168. Virol J. 2013. PMID: 23718853 Free PMC article.

8

Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis.

Chen L, Xu X, Wen X, Xu S, Wang L, Lu W, Jiang M, Huang J, Yang D, Wang J, Zheng M, Zhou XZ, Lu KP, Liu H. Chen L, et al. Among authors: zheng m. Cancer Sci. 2019 Aug;110(8):2442-2455. doi: 10.1111/cas.14085. Epub 2019 Jun 25. Cancer Sci. 2019. PMID: 31148345 Free PMC article.

9

Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1-mediated EMT.

Zhang N, Zhang S, Wu W, Lu W, Jiang M, Zheng N, Huang J, Wang L, Liu H, Zheng M, Wang J. Zhang N, et al. Among authors: zheng n, zheng m. Mol Carcinog. 2021 Feb;60(2):151-163. doi: 10.1002/mc.23279. Epub 2021 Jan 11. Mol Carcinog. 2021. PMID: 33428809

10

PIN1 Inhibition Sensitizes Chemotherapy in Gastric Cancer Cells by Targeting Stem Cell-like Traits and Multiple Biomarkers.

Zhang ZZ, Yu WX, Zheng M, Liao XH, Wang JC, Yang DY, Lu WX, Wang L, Zhang S, Liu HK, Zhou XZ, Lu KP. Zhang ZZ, et al. Among authors: zheng m. Mol Cancer Ther. 2020 Mar;19(3):906-919. doi: 10.1158/1535-7163.MCT-19-0656. Epub 2019 Dec 26. Mol Cancer Ther. 2020. PMID: 31879364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,612 results

Search Page

Filters